Brief: Novan Announces Last Patient Visit At Week 24 In Phase 3 Trial Of SB206
28/07/2021 13:19
July 28 (Reuters) - Novan Inc NOVN.O :
* NOVAN ANNOUNCES LAST PATIENT VISIT AT WEEK 24 IN B-SIMPLE4
PIVOTAL PHASE 3 TRIAL OF SB206 IN PATIENTS WITH MOLLUSCUM
CONTAGIOSUM
* NOVAN INC - INTENDS TO SUBMIT NDA FOR SB206 NO LATER THAN
Q3 OF
2022
Source text for Eikon: ID:nGNX6HqSz3
Further company coverage: NOVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NVN Liquidation
See all newsBrief: Nvn Liquidation Says On April 30, Debtors Filed Notice Of Effective Date With Bankruptcy Court
Brief: Novan Received Notice From Nasdaq Notifying Co's Securities Will Be Delisted From Nasdaq
Brief: Novan Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. STOCKS ON THE MOVE-Lands' End, Energy sector
U.S. STOCKS ON THE MOVE-Biogen, NetApp, LyondellBasell